269 related articles for article (PubMed ID: 37629053)
41. Modulation of Retinal Atrophy With Rituximab in Multiple Sclerosis.
Lambe J; Risher H; Filippatou AG; Murphy OC; Sotirchos ES; Ehrhardt H; Ogbuokiri E; Pellegrini N; Toliver B; Luciano NJ; Davis S; Fioravante N; Kwakyi O; Prince JL; Calabresi PA; Fitzgerald KC; Saidha S
Neurology; 2021 May; 96(20):e2525-e2533. PubMed ID: 33827962
[TBL] [Abstract][Full Text] [Related]
42. Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis.
Bsteh G; Hegen H; Teuchner B; Amprosi M; Berek K; Ladstätter F; Wurth S; Auer M; Di Pauli F; Deisenhammer F; Berger T
Mult Scler; 2019 Feb; 25(2):196-203. PubMed ID: 29095097
[TBL] [Abstract][Full Text] [Related]
43. Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal study.
Oertel FC; Outteryck O; Knier B; Zimmermann H; Borisow N; Bellmann-Strobl J; Blaschek A; Jarius S; Reindl M; Ruprecht K; Meinl E; Hohlfeld R; Paul F; Brandt AU; Kümpfel T; Havla J
J Neuroinflammation; 2019 Jul; 16(1):154. PubMed ID: 31345223
[TBL] [Abstract][Full Text] [Related]
44. Retinal nerve fiber layer thickness in subgroups of multiple sclerosis, measured by optical coherence tomography and scanning laser polarimetry.
Siepman TA; Bettink-Remeijer MW; Hintzen RQ
J Neurol; 2010 Oct; 257(10):1654-60. PubMed ID: 20461397
[TBL] [Abstract][Full Text] [Related]
45. Can Optical Coherence Tomography Be Used to Guide Treatment Decisions in Adult or Pediatric Multiple Sclerosis?
Lambe J; Murphy OC; Saidha S
Curr Treat Options Neurol; 2018 Mar; 20(4):9. PubMed ID: 29564662
[TBL] [Abstract][Full Text] [Related]
46. Optical coherence tomography assessment of axonal and neuronal damage of the retina in patients with familial and sporadic multiple sclerosis.
Grudziecka Pyrek M; Selmaj K
Front Neurol; 2022; 13():953188. PubMed ID: 36188381
[TBL] [Abstract][Full Text] [Related]
47. Longitudinal stability of inter-eye differences in optical coherence tomography measures for identifying unilateral optic nerve lesions in multiple sclerosis.
Patil SA; Joseph B; Tagliani P; Sastre-Garriga J; Montalban X; Vidal-Jordana A; Galetta SL; Balcer LJ; Kenney RC
J Neurol Sci; 2023 Jun; 449():120669. PubMed ID: 37167654
[TBL] [Abstract][Full Text] [Related]
48. Comparison of point estimates and average thicknesses of retinal layers measured using manual optical coherence tomography segmentation for quantification of retinal neurodegeneration in multiple sclerosis.
Sotirchos ES; Seigo MA; Calabresi PA; Saidha S
Curr Eye Res; 2013 Jan; 38(1):224-8. PubMed ID: 22954302
[TBL] [Abstract][Full Text] [Related]
49. Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis.
Schneider E; Zimmermann H; Oberwahrenbrock T; Kaufhold F; Kadas EM; Petzold A; Bilger F; Borisow N; Jarius S; Wildemann B; Ruprecht K; Brandt AU; Paul F
PLoS One; 2013; 8(6):e66151. PubMed ID: 23805202
[TBL] [Abstract][Full Text] [Related]
50. Trans-synaptic degeneration in the optic pathway: Exploring the role of lateral geniculate nucleus in early stages of relapsing-remitting multiple sclerosis.
Miante S; Margoni M; Moretto M; Pengo M; Carmisciano L; Spolettini P; Silvestri E; Danieletto M; Franciotta S; Miscioscia A; Bertoldo A; Puthenparampil M; Gallo P
Mult Scler Relat Disord; 2023 Sep; 77():104877. PubMed ID: 37454566
[TBL] [Abstract][Full Text] [Related]
51. Gray Matter Atrophy in the Cortico-Striatal-Thalamic Network and Sensorimotor Network in Relapsing-Remitting and Primary Progressive Multiple Sclerosis.
Cao Y; Diao W; Tian F; Zhang F; He L; Long X; Zhou F; Jia Z
Neuropsychol Rev; 2021 Dec; 31(4):703-720. PubMed ID: 33582965
[TBL] [Abstract][Full Text] [Related]
52. Swept-Source Optical Coherence Tomography Thresholds in Differentiating Clinical Outcomes in a Real-World Cohort of Treatment-Naïve Multiple Sclerosis Patients.
Rzepiński Ł; Kucharczuk J; Tkaczyńska M; Parisi V; Grzybowski A
Brain Sci; 2023 Mar; 13(4):. PubMed ID: 37190556
[TBL] [Abstract][Full Text] [Related]
53. Magnetic resonance imaging and optical coherence tomography correlations in multiple sclerosis beyond anatomical landmarks.
Barreiro-González A; Sanz MT; Carratalà-Boscà S; Pérez-Miralles F; Alcalá C; Carreres-Polo J; España-Gregori E; Casanova B
J Neurol Sci; 2020 Dec; 419():117180. PubMed ID: 33091751
[TBL] [Abstract][Full Text] [Related]
54. Association of retinal vessel pathology and brain atrophy in relapsing-remitting multiple sclerosis.
Romahn EF; Wiltgen T; Bussas M; Aly L; Wicklein R; Noll C; Berthele A; Dehmelt V; Mardin C; Zimmer C; Korn T; Hemmer B; Kirschke JS; Mühlau M; Knier B
Front Immunol; 2023; 14():1284986. PubMed ID: 38090586
[TBL] [Abstract][Full Text] [Related]
55. Serum amino acid profiling in differentiating clinical outcomes of multiple sclerosis.
Rzepiński Ł; Kośliński P; Kowalewski M; Koba M; Maciejek Z
Neurol Neurochir Pol; 2023; 57(5):414-422. PubMed ID: 37526173
[TBL] [Abstract][Full Text] [Related]
56. Retinal Thickness Analysis in Progressive Multiple Sclerosis Patients Treated With Epigallocatechin Gallate: Optical Coherence Tomography Results From the SUPREMES Study.
Klumbies K; Rust R; Dörr J; Konietschke F; Paul F; Bellmann-Strobl J; Brandt AU; Zimmermann HG
Front Neurol; 2021; 12():615790. PubMed ID: 33995239
[No Abstract] [Full Text] [Related]
57. Association between retinal thickness and disease characteristics in adult epilepsy: A cross-sectional OCT evaluation.
Delazer L; Bao H; Lauseker M; Stauner L; Nübling G; Conrad J; Noachtar S; Havla J; Kaufmann E
Epilepsia Open; 2024 Feb; 9(1):236-249. PubMed ID: 37920967
[TBL] [Abstract][Full Text] [Related]
58. Use of retinal optical coherence tomography to differentiate suspected neuromyelitis optica spectrum disorder from multiple sclerosis: A cross-sectional study.
Ayoubi NKE; Moussa H; Younes A; Haddad R; Khoury SJ
Mult Scler Relat Disord; 2022 Dec; 68():104160. PubMed ID: 36113276
[TBL] [Abstract][Full Text] [Related]
59. Subclinical neurodegeneration in multiple sclerosis and neuromyelitis optica spectrum disorder revealed by optical coherence tomography.
Pisa M; Ratti F; Vabanesi M; Radaelli M; Guerrieri S; Moiola L; Martinelli V; Comi G; Leocani L
Mult Scler; 2020 Sep; 26(10):1197-1206. PubMed ID: 31392924
[TBL] [Abstract][Full Text] [Related]
60. Optical Coherence Tomography in Neuromyelitis Optica spectrum disorder and Multiple Sclerosis: A population-based study.
Ashtari F; Ataei A; Kafieh R; Khodabandeh Z; Barzegar M; Raei M; Dehghani A; Mansurian M
Mult Scler Relat Disord; 2021 Jan; 47():102625. PubMed ID: 33227631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
